Intravenous iron as standard of care in oncology: opportunity lost.
Auerbach
Michael
M
Georgetown University, Washington, DC, USA. mauerbachmd@aol.com
Ballard
Harold
H
D000465:Algorithms; D000740:Anemia / Q000139:chemically induced / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects; D006397:Hematinics / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D058085:Iron Compounds / Q000627:therapeutic use*; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy*
D000970:Antineoplastic Agents; D006397:Hematinics; D058085:Iron Compounds